Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q1 2025 · 10-Q
Revenue$673.88M$673.88M−74.2% vs Q1 2024 Net Income-$24.98M-$24.98MN/M vs Q1 2024 EPS Diluted-$0.32-$0.32N/M vs Q1 2024 Gross Profit$526,013,000−1.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flow-$35,066,000N/M Free Cash Flowderived-$80,859,000N/M Margins · derivedGross margin78.1%+57.6 pt vs Q1 2024
Operating margin2.9%+2.6 pt vs Q1 2024
Net margin-3.7%−2.9 pt vs Q1 2024
ended Mar 31, 2025 · filed May 8, 2025 · 38 d after period end